Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal
SHR Neuro Krebs Kardio Stoffw Microb Lipid

Frühmarker für invasive Pilzinfektionen bei Patienten mit hämato-onkologischer Grunderkrankung

Schlagworte
Diagnostik in der Medizin
Hämatologie
Medizinische Mikrobiologie
Serologie
Projektleitung:
Hönigl Martin
Laufzeit:
01.07.2013-30.09.2015
Programm:
Jubiläumsfonds (ÖNB)
Art der Forschung
Klinische Studie
Mitarbeiter*innen
Hönigl, Martin, Projektleiter*in
Beteiligte MUG-Organisationseinheiten
Universitätsklinik für Innere Medizin - Gemeinsame Einrichtung
Gefördert durch
Österreichische Nationalbank (Jubiläumsfonds), Otto Wagner Platz 3, A-1090 Wien, Österreich
Publizierte Projektergebnisse
> Point-of-care testing for viral-associated pulmona... Expert Rev Mol Diagn. 2024; 24(3):231-243
> Triacetylfusarinine C: A urine biomarker for diagn... J Infect. 2019; 78(2):150-157
> Galactomannan testing and Aspergillus PCR in same-... Med Mycol. 2017; 55(5):528-534
> Posaconazole plasma exposure correlated to intesti... Eur J Clin Pharmacol. 2016; 72(8):953-963
> Specificity of mannan antigen and anti-mannan anti... Mycoses. 2016; 59(6):374-378
> Chemotherapy-Induced Intestinal Mucosal Barrier Da... J Clin Microbiol. 2016; 54(3):798-801
> Prognostic potential of 1,3-beta-d-glucan levels i... J Infect. 2016; 72(1):29-35
> Diagnostic performance of 1,3-beta-D-glucan serum ... Transpl Infect Dis. 2016; 18(3):466-470
> Posaconazole Plasma Concentrations on Days Three t... Antimicrob Agents Chemother. 2016; 60(9):5595-5599
> Urine Galactomannan-to-Creatinine Ratio for Detect... J Clin Microbiol. 2016; 54(3):771-774
> Diagnostic accuracy of the Aspergillus-specific br... Mycoses. 2015; 58(8):461-469
> Identification of invasive fungal diseases in immu... Mycoses. 2015; 58(12):735-745
> Detection of (1→3)-β-D-glucan in same-day urine an... Mycoses. 2015; 58(7):394-398
> Multicenter evaluation of a lateral-flow device te... Crit Care. 2015; 19(5):178-178
> Influence of mould-active antifungal treatment on ... Int J Antimicrob Agents. 2015; 46(4):401-405
> Bronchoalveolar lavage fluid sample pretreatment w... J Infect. 2015; 70(5): 541-543.
> Performance of galactomannan, beta-d-glucan, Asper... J Clin Microbiol. 2014; 52(6):2039-2045
> PERFORMANCE OF GALACTOMANNAN, ASPERGILLUS LATERAL ... . 2014; -24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); May 10-13, 2014; Barcelona, SPAIN.
> Serum and urine galactomannan testing for screenin... Med Mycol. 2014; 52(6):647-652
> Serum and Urine Galactomannan Testing for Screenin... . 2013; -53 rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); SEP 10-13, 2013; Denver, USA..
> Comparision of Galactomannan and Beta-D-Glucan Ser... . 2013; -53 rdInterscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); SEP 10-13, 2013; Denver, USA.
> Voriconazole Therapeutic Drug Monitoring in Hemato... . 2013; -23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); APR 27-30, 2013; Berlin, GERMANY.
> Comparision of galactomannan and beta-D-glucan ser... MYCOSES. 2013; 56: 71-72.-6th Trends in Medical Mycology; OCT 11-14, 2014; Kopenhagen, DENMARK.
© Med Uni Graz Impressum